BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37058782)

  • 1. Syntheses and evaluation of acridone derivatives as anticancer agents targeting Kras promoter i-motif structure.
    Wei Z; Lin X; Wang S; Zhang J; Ji D; Gong X; Huang ZS; Shu B; Li D
    Bioorg Chem; 2023 Jul; 136():106526. PubMed ID: 37058782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and evaluation of acridone-naphthalimide derivatives for regulating oncogene PDGFR-β expression.
    Zhang M; Wei Z; Gong X; Li X; Kang S; Wang J; Liu B; Huang ZS; Li D
    Bioorg Med Chem; 2021 Mar; 34():116042. PubMed ID: 33561716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and evaluation of new acridone derivatives for selective binding of oncogene c-myc promoter i-motifs in gene transcriptional regulation.
    Shu B; Cao J; Kuang G; Qiu J; Zhang M; Zhang Y; Wang M; Li X; Kang S; Ou TM; Tan JH; Huang ZS; Li D
    Chem Commun (Camb); 2018 Feb; 54(16):2036-2039. PubMed ID: 29411851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
    Oyedele AS; Bogan DN; Okoro CO
    Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of acridone-2-carbohydrazide derivatives as p-AKT Ser
    Yadav TT; Kumar MS; Bajaj S; Yc M
    Future Med Chem; 2023 Apr; 15(8):699-716. PubMed ID: 37170843
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-activity relationship of novel acridone derivatives as antiproliferative agents.
    Chen JN; Wu XK; Lu CH; Li X
    Bioorg Med Chem; 2021 Jan; 29():115868. PubMed ID: 33191085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Acridine/Acridone Analogs as Potential Anticancer Agents.
    Gensicka-Kowalewska M; Cichorek M; Ronowska A; Deptuła M; Klejbor I; Dzierzbicka K
    Med Chem; 2019; 15(7):729-737. PubMed ID: 30324889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
    Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
    Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural optimizations and bioevaluation of N-substituted acridone derivatives as strong topoisomerase II inhibitors.
    Li ZY; Xu GS; Song YL; Li X
    Bioorg Chem; 2022 Feb; 119():105543. PubMed ID: 34929515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.
    Kaur M; Singh P
    Bioorg Med Chem Lett; 2019 Jan; 29(1):32-35. PubMed ID: 30446310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel amides based on acridone scaffold with interesting antineoplastic activity.
    Mahajan AA; Rane RA; Amritkar AA; Naphade SS; Miniyar PB; Bangalore PK; Karpoormath R
    Anticancer Agents Med Chem; 2015; 15(5):555-64. PubMed ID: 25469511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment.
    Zhang B; Wang N; Zhang C; Gao C; Zhang W; Chen K; Wu W; Chen Y; Tan C; Liu F; Jiang Y
    Eur J Med Chem; 2017 Mar; 129():337-348. PubMed ID: 28237663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors.
    Eissa IH; Metwaly AM; Belal A; Mehany ABM; Ayyad RR; El-Adl K; Mahdy HA; Taghour MS; El-Gamal KMA; El-Sawah ME; Elmetwally SA; Elhendawy MA; Radwan MM; ElSohly MA
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900123. PubMed ID: 31463953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties.
    Veligeti R; Madhu RB; Anireddy J; Pasupuleti VR; Avula VKR; Ethiraj KS; Uppalanchi S; Kasturi S; Perumal Y; Anantaraju HS; Polkam N; Guda MR; Vallela S; Zyryanov GV
    Sci Rep; 2020 Nov; 10(1):20720. PubMed ID: 33244007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.